These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12412288)

  • 1. [Acute lymphoblastic leukemia with p190 type bcr/abl chimeric mRNA at relapse].
    Choi I; Matsushima T; Fujii T; Shiratsuchi M; Abe Y; Nishimura J; Nawata H; Muta K
    Rinsho Ketsueki; 2002 Sep; 43(9):836-40. PubMed ID: 12412288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A late-appearing Philadelphia chromosome in acute lymphoblastic leukemia confirmed by expression of BCR-ABL mRNA.
    Tsuchiya H; Migita M; Yamamori S; Kaneko Y; Adachi N; Nakamura T; Nobukuni Y; el-Sonbaty SS; Matsuda I
    Leukemia; 1995 Oct; 9(10):1689-93. PubMed ID: 7564511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
    Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
    Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Philadelphia chromosome in a patient with acute lymphoblastic leukemia.
    Chen L; Stamatoullas A; Bastard C; Tilly H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):132-5. PubMed ID: 15262432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Philadelphia chromosome-positive acute lymphoblastic leukemia showing normal karyotype at presentation].
    Maki K; Nakamura F; Gunji H; Arai Y; Mitani K
    Rinsho Ketsueki; 2003 Nov; 44(11):1110-2. PubMed ID: 14689877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial.
    Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R;
    Haematologica; 2006 Mar; 91(3):377-80. PubMed ID: 16531262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute lymphocytic leukemia with Philadelphia chromosome and rearrangements of bcr gene and deletion of 5' side and of TCR-delta gene].
    Ohnishi A; Kagiyama S; Shintate Y; Kimura N; Ohgami A; Takechi M; Tanaka K; Kamada N
    Rinsho Ketsueki; 1990 Jun; 31(6):820-6. PubMed ID: 2145450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minor bcr/abl positive acute lymphoblastic leukemia preceded by knee joint pain due to bone marrow necrosis].
    Sato K; Mori M; Meguro A; Miyoshi T; Nagai T; Muroi K; Komatsu N; Ozawa K
    Rinsho Ketsueki; 2004 Nov; 45(11):1203-7. PubMed ID: 15609688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P190-type bcr/abl expressed in myeloid colonies in a patient with Ph1-positive acute lymphoblastic leukemia.
    Sadamura S; Umemura T; Hirata J; Takahira H; Yufu Y; Abe Y; Nishimura J; Nawata H
    Leukemia; 1992 Aug; 6(8):791-5. PubMed ID: 1640730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia.
    Kim J; Park TS; Lyu CJ; Song J; Lee KA; Kim SJ; Lee HJ; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):132-7. PubMed ID: 19215796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3q21q26 syndrome with minor-BCR/ABL type Ph chromosome].
    Hirabayashi K; Kawakami H; Kodaira H
    Rinsho Ketsueki; 2003 Dec; 44(12):1166-71. PubMed ID: 14978933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
    Jándula BM; Nomdedeu J; Marín P; Vivancos P
    Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia.
    Burmeister T; Schwartz S; Taubald A; Jost E; Lipp T; Schneller F; Diedrich H; Thomssen H; Mey UJ; Eucker J; Rieder H; Gökbuget N; Hoelzer D; Thiel E
    Haematologica; 2007 Dec; 92(12):1699-702. PubMed ID: 18055996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.